Hilar Cholangiocarcinoma — Trials

Hilar Cholangiocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

62 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 13
Recruiting: 9
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03353181	Application of Endoscopic Scissors Cutting ENBD Tube in the Treatment of Malignant Hilar Biliary Strictures(ENBD)	withdrawn	N/A	0	Changhai HospitalOTHER	1	Aug 25, 2022	clinicaltrials
NCT02856568	Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma	withdrawn	Phase 1	0	Mayo ClinicOTHER	1	May 30, 2017	clinicaltrials